Home
Market Capitalization of Jenburkt Pharmaceuticals Ltd

Jenburkt Pharmaceuticals Ltd
NSE: JENBURKTPHARMA
Market Cap
Key Highlights
- The Market Cap of Jenburkt Pharmaceuticals Ltd is ₹ 443.23 crore as of 21 Feb 25 .
- The Latest Trading Price of Jenburkt Pharmaceuticals Ltd is ₹ 1004 as of 21 Feb 15:30 .
- The Dividend Payouts of Jenburkt Pharmaceuticals Ltd changed from ₹ 10.2 on Jul 22, 2019 to ₹ 15.3 on Jul 23, 2024 . This represents a CAGR of 6.99% over 6 years.

Jenburkt Pharmaceuticals Ltd
NSE: JENBURKTPHARMA
Share Price
Market Price of Jenburkt Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 1004.3 |
20 Feb 2025 | 1023.25 |
19 Feb 2025 | 1019.4 |
18 Feb 2025 | 966.7 |
17 Feb 2025 | 1017 |
14 Feb 2025 | 1029.05 |
13 Feb 2025 | 1095.25 |
12 Feb 2025 | 1069.85 |
11 Feb 2025 | 1056.8 |
10 Feb 2025 | 1089.45 |
SWOT Analysis Of Jenburkt Pharmaceuticals Ltd
BlinkX Score for Jenburkt Pharmaceuticals Ltd
Asset Value vs Market Value of Jenburkt Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Jenburkt Pharmaceuticals Ltd
Historical P/E Ratio of Jenburkt Pharmaceuticals Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Jenburkt Pharmaceuticals Ltd
Historical Revenue of Jenburkt Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Jenburkt Pharmaceuticals Ltd
Historical EBITDA of Jenburkt Pharmaceuticals Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Jenburkt Pharmaceuticals Ltd
Historical Net Profit of Jenburkt Pharmaceuticals Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Jenburkt Pharmaceuticals Ltd
Historical Dividend Payouts of Jenburkt Pharmaceuticals Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payouts of Jenburkt Pharmaceuticals Ltd
About Jenburkt Pharmaceuticals Ltd
- Jenburkt Pharmaceuticals Ltd, incorporated in 1985, was formed a venture to diversify into the healthcare and pharmaceutical industry, by Bhuta family.
- The Company is engaged in manufacturing and marketing of speciality and high quality pharmaceutical formulations and healthcare products. Presently, the Company manufactures and markets pharmaceutical formulations in India and internationally across 13 countries.
- It has more than 1,000 stockists and their reach extends to 400,000+ pharmacies across the globe.
- The organisation caters to government, semi-government institutions, missionary hospitals, public sector enterprises, etc. Apart from this. the Company operate manufacturing plant at Sihor-Gujarat, approved as per W.H.O (World Health Organisation) guidelines with current Good Manufacturing Practices (GMP) requirements.
Jenburkt Pharmaceuticals Ltd News Hub
Jenburkt Pharmaceuticals to announce Quarterly Result
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November
Read more
29 Oct 24
Jenburkt Pharmaceuticals standalone net profit rises 31.15% in the September 2024 quarter
Net profit of Jenburkt Pharmaceuticals rose 31.15% to Rs 9.60 crore in the quarter ended September 2
Read more
05 Nov 24
Jenburkt Pharmaceuticals to table results
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 January
Read more
21 Jan 25
Jenburkt Pharmaceuticals standalone net profit rises 20.56% in the December 2024 quarter
Net profit of Jenburkt Pharmaceuticals rose 20.56% to Rs 6.51 crore in the quarter ended December 20
Read more
29 Jan 25